SCI Ventures Overview
SCI Ventures is a novel, evergreen fund created to catalyze innovative cures for paralysis. Backed by leading foundations for spinal cord injury in the US and Europe, and advised by world-class neuroscientists, SCI Ventures invests in early-stage companies developing cure-oriented therapies for spinal cord injury and related markets. The fund focuses on companies with the greatest potential to impact its mission, typically at the Seed and Series A stages.
Is SCI Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with SCI Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
SCI Ventures
Investment focus
Product type
- Software-enabled hardware
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- MedTech & Devices
Stages
Seed, Series A
First ticket size
US$1,000,000 - US$10,000,000
How to approach funds like SCI Ventures
When approaching SCI Ventures, founders should highlight the scientific rigor and translational potential of their technology, especially how it addresses critical bottlenecks in spinal cord injury treatment. Demonstrate a clear path from preclinical validation to clinical impact, and articulate how your team’s expertise and partnerships can accelerate progress toward functional cures. Emphasize alignment with patient-centric outcomes and readiness to collaborate with leading academic and clinical stakeholders.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
